David. M. Nagorney

David. M. Nagorney's AcademicInfluence.com Rankings

David. M. Nagorney

Philosophy

#5226

World Rank

#7972

Historical Rank

Logic

#2539

World Rank

#3545

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is David. M. Nagorney Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David. M. Nagorney's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Immune Landscape of Cancer (2018) (2766)
Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
The International Position on Laparoscopic Liver Surgery: The Louisville Statement, 2008 (2009) (1353)
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. (2009) (1176)
Diagnosis and management of primary sclerosing cholangitis (2010) (1097)
Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. (2003) (714)
Simplified staging for hepatocellular carcinoma. (2002) (667)
Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar Cholangiocarcinoma (2005) (568)
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma (2005) (547)
Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival (2008) (537)
Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
Biliary tract cancers. (1999) (486)
Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas (2002) (483)
Hepatic resection for metastatic neuroendocrine carcinomas. (1995) (456)
Risk factors for mortality after surgery in patients with cirrhosis. (2007) (449)
Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma: Is Cure Possible? (2008) (421)
Complications following pancreaticoduodenectomy. Current management. (1992) (404)
Surgical management of intussusception in the adult. (1981) (404)
Carcinoid tumor of the appendix: treatment and prognosis. (1987) (390)
Total Laparoscopic Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: Oncologic Advantages Over Open Approaches? (2014) (390)
Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. (1990) (390)
Cholangiocarcinoma complicating primary sclerosing cholangitis. (1991) (379)
Hepatic resection for metastatic colorectal cancer results in cure for some patients. (1997) (371)
Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. (1990) (367)
Cytoreductive hepatic surgery for neuroendocrine tumors. (1990) (358)
A Comparison of Routine Cytology and Fluorescence in situ Hybridization for the Detection of Malignant Bile Duct Strictures (2004) (326)
The Management of Patients with Advanced Carcinoid Tumors and Islet Cell Carcinomas (1994) (285)
Hepatic Resection for Colorectal Metastases: Value for Risk Scoring Systems? (2007) (275)
Primary hepatic malignancy: surgical management and determinants of survival. (1989) (263)
The genomic landscape of small intestine neuroendocrine tumors. (2013) (259)
Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. (2000) (259)
Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. (2008) (254)
Is Hepatic Resection for Large or Multinodular Hepatocellular Carcinoma Justified? Results From a Multi-Institutional Database (2005) (245)
What prognostic factors are important in duodenal adenocarcinoma? (2000) (241)
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). (2008) (240)
Surgical treatment of hepatic and pulmonary metastases from colon cancer. (2001) (238)
Operative Management of Primary Retroperitoneal Sarcomas: A Reappraisal of an Institutional Experience (2004) (233)
Replacement of the inferior vena cava for malignancy: an update. (2000) (231)
Outcomes after curative resections of cholangiocarcinoma. (1993) (229)
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation (2002) (226)
"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. (1995) (225)
Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. (2005) (222)
Carcinoma of the gallbladder. Does radical resection improve outcome? (1990) (221)
Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. (2005) (213)
Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers (2003) (212)
Predictive indices of morbidity and mortality after liver resection. (2006) (209)
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer. (2019) (206)
External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer (1988) (197)
Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality (2005) (193)
Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. (2004) (190)
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma (2008) (186)
Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. (1993) (184)
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas (2002) (183)
Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. (2001) (177)
Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. (1995) (174)
Quality-of-life after total pancreatectomy: Is it really that bad on long-term follow-up? (2005) (170)
Acute necrotizing pancreatitis: Management by planned, staged pancreatic necrosectomy/debridement and delayed primary wound closure over drains (1991) (170)
Laparoscopic vs open distal pancreatectomy: a single-institution comparative study. (2010) (168)
Prognostic Histologic Indicators of Curatively Resected Hepatocellular Carcinomas: A Multi-institutional Analysis of 425 Patients With Definition of a Histologic Prognostic Index (2002) (167)
Concurrent vs. Staged Colectomy and Hepatectomy for Primary Colorectal Cancer With Synchronous Hepatic Metastases (2004) (167)
Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. (1993) (167)
Expression of CYP1A1 and CYP1A2 genes in human liver. (1993) (164)
Sigmoid diverticulitis with perforation and generalized peritonitis (1985) (162)
Radical resection for carcinoma of the ampulla of Vater. (1991) (161)
Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. (2010) (159)
Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. (2002) (156)
Carcinoma of the gallbladder and extrahepatic bile ducts. (1988) (153)
hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. (2004) (151)
Trends in Morbidity and Mortality of Hepatic Resection for Malignancy A Matched Comparative Analysis (1994) (151)
Medical and surgical treatment options for polycystic liver disease 1 (2010) (148)
Pancreaticoduodenectomy with Major Vascular Resection: a Comparison of Laparoscopic Versus Open Approaches (2014) (148)
Choledochal cysts in adults: clinical management. (1984) (145)
Intraoperative and External Beam Irradiation for Locally Advanced Colorectal Cancer (1988) (145)
miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. (2010) (144)
Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. (2002) (143)
Long-term results of biliary reconstruction after laparoscopic bile duct injuries. (1999) (139)
Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis. (1990) (137)
Pancreatoduodenectomy for chronic pancreatitis: long-term results in 105 patients. (2000) (134)
Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: Results of a multicenter study (2004) (131)
Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. (2001) (131)
Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas (2005) (130)
Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival (2006) (129)
Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. (2009) (129)
Management of liver adenomatosis: results with a conservative surgical approach. (1998) (126)
Cholangiocarcinoma: diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography. (1988) (125)
Villous tumors of the duodenum: Reappraisal of local vs. extended resection (2007) (120)
Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. (2002) (120)
Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours. (2001) (119)
Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study. (2016) (118)
Number of Lymph Nodes Evaluated: Prognostic Value in Pancreatic Adenocarcinoma (2012) (116)
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. (2007) (114)
Polycystic Liver Disease: A Critical Appraisal of Hepatic Resection, Cyst Fenestration, and Liver Transplantation (2009) (113)
The International Position on Laparoscopic Liver Surgery (2009) (113)
A comparison of laparoscopic and open cholecystectomy in patients with compensated cirrhosis and symptomatic gallstone disease. (2000) (111)
Open versus laparoscopic splenectomy for idiopathic thrombocytopenic purpura: clinical and economic analysis. (2003) (109)
Benign hepatic tumors: Focal nodular hyperplasia and hepatocellular adenoma (2004) (109)
Microvascular Invasion Does Not Predict Long-Term Survival in Hepatocellular Carcinoma up to 2 cm: Reappraisal of the Staging System for Solitary Tumors (2013) (108)
Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. (1998) (108)
Primary venous leiomyosarcoma: a rare but lethal disease. (1992) (107)
Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy (2013) (105)
Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer. (1987) (104)
Unique genomic profile of fibrolamellar hepatocellular carcinoma. (2015) (104)
Surgical treatment of hepatocellular carcinoma: expert consensus statement. (2010) (103)
Spectrum and management of major complications of laparoscopic cholecystectomy. (1993) (102)
Gallbladder cancer discovered during laparoscopic surgery: potential for iatrogenic tumor dissemination. (1994) (98)
Duodenal carcinoid tumors: How aggressive should we be? (2001) (97)
Chronic pancreatitis. Results of Whipple's resection and total pancreatectomy. (1988) (97)
Clinical Risk Score to Predict Pancreatic Fistula after Pancreatoduodenectomy: Independent External Validation for Open and Laparoscopic Approaches. (2015) (97)
Pancreas-sparing duodenectomy for duodenal polyposis. (2002) (96)
Management of giant hemangioma of the liver: resection versus observation. (2010) (96)
Benign biliary strictures: repair and outcome with a contemporary approach. (1995) (94)
Diagnosis and treatment of Mirizzi syndrome: 23-year Mayo Clinic experience. (2011) (93)
High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer. (1993) (90)
Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? (2010) (90)
Iatrogenic Hepatic Artery Pseudoaneurysms: An Uncommon Complication after Hepatic, Biliary, and Pancreatic Procedures (2003) (89)
The mayo clinic experience with multimodality treatment of locally advanced or recurrent colon cancer (2002) (86)
Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. (1984) (84)
Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia (1994) (82)
Treatment of Neuroendocrine Cancer Metastatic to the Liver: The Role of Ablative Techniques (2005) (82)
Comparison of Preoperative Serum CA19‐9 Levels with Results of Diagnostic Imaging Modalities in Patients Undergoing Laparotomy for Suspected Pancreatic or Gallbladder Disease (1994) (81)
Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer (1996) (81)
Comparison of Clinicopathologic Characteristics and Outcomes After Resection in Patients With Hepatocellular Carcinoma Treated in the United States, France, and Japan (2003) (78)
Liver-Directed Therapy for Hepatic Metastases in Patients Undergoing Pancreaticoduodenectomy: A Dual-Center Analysis (2010) (77)
Intraductal papillary mucinous neoplasm of the biliary tract: a real disease? (2009) (77)
Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66. (2010) (77)
Hepatic resection for metachronous metastases from ovarian carcinoma. (2003) (76)
Pancreatoduodenectomy for Ductal Adenocarcinoma in the Very Elderly; Is It Safe and Justified? (2010) (75)
Indications and Perioperative Outcomes for Pancreatectomy with Arterial Resection. (2018) (74)
Resection of ‘recurrent’ colorectal metastases to the liver (1994) (73)
Vena cava replacement for malignant disease: Is there a role? (1993) (71)
Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. (1998) (70)
Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis. (2015) (69)
Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience (2000) (69)
Hepatic resection for noncolorectal, nonneuroendocrine metastases (2005) (69)
Cholangiocarcinoma: is transplantation an option? For whom? (2007) (69)
Bronchogenic carcinoma in patients younger than 40 years. (1983) (68)
Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database. (2016) (68)
Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management. (1995) (68)
Transplantation for cholangiocarcinoma: when and for whom? (2009) (67)
The Role of Defective Mismatch Repair in Small Bowel Adenocarcinoma in Celiac Disease (2004) (67)
Hepatocellular carcinoma in autoimmune hepatitis. (2000) (67)
External beam and intraoperative electron irradiation for locally advanced soft tissue sarcomas. (1993) (66)
Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? (2012) (66)
Quality-of-life assessment of surgical reconstruction after laparoscopic cholecystectomy-induced bile duct injuries: what happens at 5 years and beyond? (2004) (66)
Is combined partial hepatectomy with segmental resection of inferior vena cava justified for malignancy? (2003) (63)
Extrahepatic Biliary Cystadenomas and Cystadenocarcinoma: Report of Seven Cases and Review of the Literature (1993) (63)
Temporary elevation of CA 125 after abdominal surgical treatment for benign disease and cancer. (1989) (63)
Metastatic nonfunctioning pancreatic neuroendocrine carcinoma to liver: surgical treatment and outcomes. (2012) (62)
Hepatic resection in the treatment of hilar cholangiocarcinoma. (2006) (61)
Surgical treatment of gallbladder cancer (2007) (60)
Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor. (2015) (60)
Selection for Resection of Hepatocellular Carcinoma and Surgical Strategy: Indications for Resection, Evaluation of Liver Function, Portal Vein Embolization, and Resection (2008) (59)
Cholangiocarcinoma complicating primary sclerosing cholangitis. (1991) (59)
A NSQIP Review of Major Morbidity and Mortality of Synchronous Liver Resection for Colorectal Metastasis Stratified by Extent of Liver Resection and Type of Colorectal Resection (2014) (59)
Is Liver Transplantation Appropriate for Patients with Potentially Resectable De Novo Hilar Cholangiocarcinoma? (2015) (57)
Outcomes of primary liver cancer in children: an appraisal of experience. (2007) (57)
When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations. (2015) (57)
Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection. (2013) (57)
Pancreaticoduodenectomy for Islet Cell Tumors of the Head of the Pancreas: Long-term Survival Analysis (2002) (57)
Sinistral Portal Hypertension Splenectomy or Expectant Management (1993) (56)
Postoperative intussusception in the adult: a previously unrecognized entity? (1981) (55)
Bile duct cysts: A changing spectrum of presentation (1996) (55)
Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition. (1995) (55)
15-Year Experience with Surgical Treatment of Duodenal Carcinoma: a Comparison of Periampullary and Extra-Ampullary Duodenal Carcinomas (2012) (53)
Surgical outcomes of isolated caudate lobe resection: a single series of 19 patients. (2002) (53)
Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. (2002) (52)
Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. (2019) (51)
Splenectomy for hairy cell leukemia: A clinical review of 63 patients (1986) (51)
Implications of CA19‐9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis (2016) (51)
The Mayo clinic approach to the surgical treatment of adenocarcinoma of the pancreas. (2001) (51)
Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? (2006) (50)
Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. (2005) (49)
Role of Major Vascular Resection in Patients with Intrahepatic Cholangiocarcinoma (2013) (49)
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria (2016) (48)
The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. (2008) (48)
Surgical treatment of adult primary hepatic sarcoma (2000) (48)
Hepatic localization of endothelin‐1 in patients with idiopathic portal hypertension and cirrhosis of the liver (2000) (46)
Outcome of Splenectomy for Thrombocytopenia Associated With Systemic Lupus Erythematosus (2004) (46)
Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience. (2015) (45)
Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment (1992) (45)
Intraoperative and external beam irradiation with or without resection: Mayo pilot experience. (1984) (44)
Extrahepatic biliary cystadenomas and cystadenocarcinoma. Report of seven cases and review of the literature. (1993) (44)
Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. (2006) (44)
Splenic salvage after intraoperative splenic injury during colectomy. (2009) (43)
Role of hepatic resection for patients with carcinoid heart disease. (2008) (43)
Early gastric cancer (1992) (42)
Surgical Resection of Synchronously Metastatic Adrenocortical Cancer (2014) (41)
Ossifying malignant mixed epithelial and stromal tumor of the liver (2002) (41)
Resection of hepatocellular carcinoma in patients without cirrhosis (2011) (41)
Primary leiomyosarcoma of the liver mimicking liver abscess. (1995) (41)
Resection of hepatic and pulmonary metastases in patients with colorectal cancer (1994) (41)
Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience. (2018) (39)
Splenic abscess--the importance of early diagnosis. (1983) (39)
Tumor Characteristics and Survival Analysis of Incidental Versus Suspected Gallbladder Carcinoma (2012) (38)
Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors. (2012) (38)
Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics. (2015) (38)
Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease. (2016) (38)
Comparison of analgesic requirements after liver transplantation and cholecystectomy. (1989) (37)
Use of vascular staplers in major hepatic resections (1991) (37)
Laparoscopic pancreatoduodenectomy does not completely mitigate increased perioperative risks in elderly patients. (2015) (37)
Neoadjuvant Treatment of Duodenal Adenocarcinoma: A Rescue Strategy (2011) (37)
Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma (2004) (36)
Carcinoid heart disease and carcinoid syndrome: successful surgical treatment. (1999) (36)
Isolated Crohn's disease of the stomach. (1989) (36)
Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series (2017) (35)
Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma. (2013) (35)
Allelic Imbalance and Microsatellite Instability in Resected Duke's D Colorectal Cancer (1997) (34)
Defining Perioperative Risk after Hepatectomy Based on Diagnosis and Extent of Resection (2014) (34)
En Bloc Celiac Axis Resection for Pancreatic Cancer: Classification of Anatomical Variants Based on Tumor Extent. (2020) (34)
Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience. (2017) (33)
Adjuvant Therapy for Node-Negative Breast Cancer (1989) (33)
L‐myc Proto‐oncogene alleles and susceptibility to hepatocellular carcinoma (1993) (31)
Neuroendocrine ampullary tumors: spectrum of disease including the first report of a neuroendocrine carcinoma of non-small cell type. (1994) (31)
Splenectomy in advanced chronic lymphocytic leukemia: a single institution experience with 50 patients. (1992) (30)
Does Body Mass Index/Morbid Obesity Influence Outcome in Patients Who Undergo Pancreatoduodenectomy for Pancreatic Adenocarcinoma? (2010) (30)
Survival benefit of neoadjuvant therapy in patients with non‐metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention‐to‐treat analysis (2019) (29)
Management of a delayed post-pancreatoduodenectomy haemorrhage using endovascular techniques. (2015) (29)
Hepatic resection for intrahepatic ductal stones. (1982) (29)
Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience. (2017) (29)
Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. (2013) (28)
Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study). (2018) (28)
Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma (2018) (28)
Hepatic resection for metachronous metastases from ovarian carcinoma. (2006) (27)
A Single-Institution Review of Portosystemic Shunts in Children: An Ongoing Discussion (2010) (27)
Primary epithelial hepatic malignancies: etiology, epidemiology, and outcome after subtotal and total hepatic resection. (1996) (27)
A positive lymphocyte cross-match and major histocompatibility complex mismatching do not predict early rejection of liver transplants in patients treated with cyclosporine. (1987) (27)
Hepatic resection for the carcinoid syndrome in patients with severe carcinoid heart disease: does valve replacement permit safe hepatic resection? (2011) (27)
Cytoreductive Hepatic Surgery for Metastatic Gastrointestinal Neuroendocrine Tumors (1994) (27)
Metabolic Syndrome is Associated with Increased Postoperative Morbidity and Hospital Resource Utilization in Patients Undergoing Elective Pancreatectomy (2015) (26)
Poor outcome from peritoneovenous shunts for refractory ascites. (1989) (26)
Reconstruction of the hepatic artery using the gastroduodenal artery. (2003) (26)
Right hepatectomy for living liver donation vs right hepatectomy for disease: intraoperative and immediate postoperative comparison. (2007) (26)
Inferior Vena Cava Stenting: A Safe and Effective Treatment for Intractable Ascites in Patients with Polycystic Liver Disease (2007) (25)
Hepatocellular Carcinoma inAutoimmune Hepatitis (2000) (25)
Relationship of nuclear DNA content to clinical and pathologic findings in patients with primary hepatic malignancy. (1992) (24)
Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm. (2012) (24)
Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy. (2020) (24)
Future role of radiotherapy as a component of treatment in biliopancreatic cancers. (1999) (24)
Synchronous Rectal and Hepatic Resection of Rectal Metastatic Disease (2011) (24)
Intraoperative electron radiotherapy as a component of salvage therapy for patients with colorectal cancer and advanced nodal metastases. (2003) (23)
Prognostic significance of nuclear deoxyribonucleic acid ploidy patterns in resected hepatic metastases from colorectal carcinoma. (1987) (23)
Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52. (2012) (23)
Splenectomy for Massive Splenomegaly: Long-Term Results and Risks for Mortality (2013) (23)
Hepatic duct stricture after radical radiation therapy for biliary cancer: recurrence or fibrosis? (1986) (22)
Intraoperative radiotherapy for unresectable cholangiocarcinoma--the Mayo Clinic experience. (1992) (22)
Is there a role for endoscopic therapy as a definitive treatment for post-laparoscopic bile duct injuries? (2010) (22)
Gastrointestinal stromal tumour of the duodenum: single institution experience. (2012) (21)
Outcome of portal‐systemic shunt surgery for portal hypertension associated with intrahepatic obstruction in patients with agnogenic myeloid metaplasia (1994) (21)
Duodenal duplication cyst causing massive bleeding in an adult: an unusual complication of a duplication cyst of the digestive tract. (1985) (20)
The relationship of flow cytometric DNA analysis and clinicopathology in small-intestinal carcinoids. (1989) (20)
Intermittent jaundice by tumor emboli from intrahepatic cholangiocarcinoma. (1992) (20)
Preoperative anemia is associated with increased use of hospital resources in patients undergoing elective hepatectomy. (2015) (19)
Hepatic resection in the treatment of perihilar cholangiocarcinoma. (2002) (19)
Residual, recurrent, or unresectable gastrointestinal cancer. Role of radiation in single or combined modality treatment (1985) (19)
Impact of Neoadjuvant Chemotherapy with FOLFOX/FOLFIRI on Disease-Free and Overall Survival of Patients with Colorectal Metastases (2009) (19)
Conformal irradiation for hepatobiliary malignancies. (1999) (19)
Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis (2017) (19)
External beam plus intraoperative irradiation for gastrointestinal cancers (1995) (19)
The surgical spectrum of hereditary pancreatitis in adults. (1992) (19)
Survival and Prognostic Factors in Patients With Solid Pseudopapillary Neoplasms of the Pancreas (2018) (18)
Hepatic hemodynamics after chronic obstruction of the biliary tract in the dog. (1988) (18)
Efficacy of Splenectomy for Patients with Mantle Cell Non-Hodgkin's Lymphoma (2001) (18)
Surgical Treatment of Hepatocellular Carcinoma (2017) (18)
Treatment of refractory, nonmalignant hydrothorax with a pleurovenous shunt. (1997) (18)
Heterotopic gastric mucosa in the common bile duct. (1990) (17)
Implementation of prospective, surgeon‐driven, risk‐based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million (2018) (17)
Longterm clinical and radiological follow‐up of living liver donors (2016) (17)
Portal Hypertension, Variceal Bleeding, and High Output Cardiac Failure Secondary to an Intrahepatic Arterioportal Fistula (1993) (17)
Extracorporeal shock-wave lithotripsy and methyl tert-butyl ether for partially calcified gallstones. (1989) (17)
Surgical management of chronic pancreatitis at the Mayo Clinic. (2001) (17)
Characterization of a porcine model for associating liver partition and portal vein ligation for a staged hepatectomy. (2015) (17)
Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer. (1989) (16)
Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors. (2020) (16)
Type of Resection (Whipple vs. Distal) Does Not Affect the National Failure to Provide Post-resection Adjuvant Chemotherapy in Localized Pancreatic Cancer (2017) (16)
Early Gastric Cancer (1974) (16)
Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens (2019) (16)
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer (2021) (15)
Local control and survival in locally advanced gastrointestinal cancer. (1986) (15)
Cystadenoma of the proximal common hepatic duct: the use of abdominal ultrasonography and transhepatic cholangiography in diagnosis. (1984) (15)
Bile Duct Cysts in Adults (2007) (15)
Acute acalculous cholecystitis. (1989) (15)
RTOG #89-06: a phase I study to evaluate intraoperative radiation therapy and the hypoxic cell sensitizer etanidazole in locally advanced malignancies. (1994) (15)
Duodenocaval Fistula After Irradiation and Resection of a Retroperitoneal Sarcoma (2008) (14)
Outcomes of Pancreaticoduodenectomy for Pancreatic Neuroendocrine Tumors: Are Combined Procedures Justified? (2016) (14)
AASLD PRACTICE GUIDELINES Diagnosis and Management of Primary Sclerosing Cholangitis (2010) (14)
54 Use of intraoperative electron beam radiation therapy(IOERT) in the management of retroperitoneal and pelvic soft tissue sarcomas (1996) (13)
An end-to-end pancreaticojejunostomy using a mechanical purse-string device. (1999) (13)
Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma. (2019) (13)
Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine (2020) (13)
Portal vein reconstruction during surgery for cholangiocarcinoma (2016) (12)
Safety of an Enhanced Recovery Pathway for Patients Undergoing Open Hepatic Resection (2016) (12)
Pancreatoduodenectomy for Chronic Pancreatitis—Results of a Pain Relief and Quality of Life Survey 15 Years Following Operation (2015) (12)
External beam vs. intraoperative and external beam irradiation for locally advanced pancreatic cancer (1986) (11)
Surgical Management of Cystic Disease of the Liver (2007) (11)
Partial hepatic resections for metastatic neuroendocrine tumors: perioperative outcomes. (2018) (11)
Synchronous resection of colorectal cancer primary and liver metastases: an outcomes analysis. (2021) (11)
Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty‐nine patients (2018) (11)
ERCP for the treatment of bile leak after partial hepatectomy and fenestration for symptomatic polycystic liver disease. (2012) (11)
Long-term outcome of cholecystoenterostomy as a definitive biliary drainage procedure for benign disease (1995) (11)
Radiation Therapy for Retroperitoneal Sarcomas: Influences of Histology, Grade, and Size (2018) (11)
Hypophosphatemia after right hepatectomy for living donor liver transplantation. (2004) (10)
Analysis of failure following curative irradiation of extrahepatic bile duct carcinoma (1986) (10)
Successful endoscopic treatment of a complete transection of the bile duct complicating laparoscopic cholecystectomy. (2003) (10)
Final results of hepatic arterial infusion (HAI) plus systemic (SYS) chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic (M-CRC) to the liver: A North Central Cancer Treatment Group (NCCTG) phase II study. (2004) (10)
Localized hepatocellular carcinoma: Therapeutic options (2000) (10)
A Curative-Intent Trimodality Approach for Isolated Abdominal Nodal Metastases in Metastatic Colorectal Cancer: Update of a Single-Institutional Experience. (2018) (10)
Patterns of Pancreatic Resection Differ Between Patients with Familial and Sporadic Pancreatic Cancer (2011) (10)
Resection of a giant primary synovial sarcoma of the inferior vena cava extending into the right atrium with caval reconstruction under cardiopulmonary bypass and circulatory arrest. (2012) (9)
Bile duct cysts: contemporary surgical management (2009) (9)
Peritumoral steatosis associated with insulinomas: appearance at imaging (2008) (9)
Perihilar Bile Ducts (2017) (9)
Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery (2020) (9)
Biliary Tract IORT (1999) (9)
The role of portosystemic shunts for variceal bleeding in the liver transplantation era. (1994) (9)
Modern Chemotherapy Mitigates Adverse Prognostic Effect of Regional Nodal Metastases in Stage IV Colorectal Cancer (2013) (8)
Hepatocellular Carcinoma: A Western Perspective (1995) (8)
Management of peri-pancreatic vasculature during pancreatoduodenectomy: tips to avoid severe haemorrhage. (1999) (8)
Transversus abdominis plane blocks with liposomal bupivacaine after open major hepatectomy is associated with reduced early patient‐reported pain scores and opioid administration☆ (2018) (8)
Multilocular cystic hepatocellular carcinoma (CHCC) mimicking mucinous cystadenocarcinoma. (2003) (7)
External beam and intraoperative electron irradiation for colorectal cancer (1986) (7)
Liver metastases : biology, diagnosis, and treatment (1998) (7)
Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosis (2018) (7)
Portal Venous Thrombosis After Distal Pancreatectomy: Clinical Outcomes (2014) (7)
Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease. (2020) (7)
Hepatic Resection for Metastatic Neuroendocrine Cancer in Patients with Bone Metastases (2016) (7)
Are Hepatic Adenomas Premalignant? (1996) (7)
A use for the stapler in pancreatic surgery. (1981) (7)
Combined APRI/ALBI score to predict mortality after hepatic resection (2021) (6)
Development and application of methodology for assessing the role of lysosomes in experimental ulcerogenesis in the guinea pig. (1983) (6)
Hepatic adenomatosis in a young woman with glucose intolerance (2006) (6)
"Answers in hours": A prospective clinical study using nanopore sequencing for bile duct cultures. (2021) (5)
Selective management of hepatic venous outflow obstruction (1997) (5)
Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patients (2020) (5)
Adjuvant Radiation and Chemotherapy for Pancreatic Adenocarcinoma: The Mayo Clinic Experience (2007) (5)
Resolution of recurrent Verner-Morrison syndrome by resection of metastatic vipoma. (1983) (5)
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma. (2022) (4)
PERIANESTHETIC RISKS AND OUTCOMES OF ABDOMINAL SURGERY FOR METASTATIC CARCINOID TUMORS (1998) (4)
SS27 Outcomes of 102 Patients Treated With Segmental Inferior Vena Cava Resection and Graft Replacement for Malignant Disease (2014) (4)
Preoperative opioid use is associated with increased length of stay after pancreaticoduodenectomy. (2019) (4)
Ulcerative colitis, infliximab, and hepatic epithelioid hemangioendothelioma: who is to blame? Case Report (2010) (4)
Intrahepatic biliary cystadenomas with and without mesenchymal stroma (1999) (4)
Significance of proximal ductal margin status after resection of hilar cholangiocarcinoma. (2020) (4)
Stapled cholecystojejunostomy and gastrojejunostomy for the palliation of unresectable pancreatic carcinoma. (1986) (4)
The impact of hepatic venous anatomy on the hepatic remnant: need for assessment? (2010) (4)
Splenectomy for Conditions Other Than Trauma (2019) (4)
Idiopathic benign biliary strictures in surgically resected patients with presumed cholangiocarcinoma. (2005) (4)
Correlation of DNA ploidy, histopathology, stage and clinical outcome in gastric carcinoma. (1992) (4)
Operative Ultrasound of the Liver and Biliary Ducts (1987) (4)
Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancer. (2022) (3)
Necrotic ulcerations after splenectomy (2015) (3)
Splenectomy for Massive Splenomegaly Associated with Myelofibrosis: Outcomes From 63 Patients At Mayo Clinic. (2012) (3)
Intraoperative bile duct cultures in patients undergoing pancreatic head resection: Prospective comparison of bile duct swab versus bile duct aspiration. (2021) (3)
Contemporary outcomes of pancreaticoduodenectomy for benign and precancerous cystic lesions. (2022) (3)
Safety of same-day sequential extracorporeal shock wave lithotripsy and dissolution of gallstones by methyl tert-butyl ether in dogs. (1990) (3)
Pancreatoduodenectomy for Chronic Pancreatitis (2015) (3)
Commentary on "can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?". (2015) (3)
Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in Adults (2020) (3)
Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease (2019) (3)
Critical evaluation of the different staging systems for hepatocellular carcinoma (Br J Surg 2004; 91: 400‐408) (2004) (3)
Challenges in patient selection for liver resection or transplantation in patients with hepatocellular carcinoma beyond Milan criteria. (2017) (3)
TYPE IVA CHOLEDOCHAL CYST: IS HEPATIC RESECTION NECESSARY? (1994) (3)
Long Term Clinical Outcomes in Patients with Massive Splenomegaly and Non-Hodgkin's Lymphoma Treated with Splenectomy. (2012) (3)
Synchronous colorectal liver metastases: therapeutic considerations. (2021) (3)
804 Does Neoadjuvant Chemotherapy with FOLFOX- or FOLFIRI Improve the Disease-Free Interval or Survival of Patients with Colorectal Metastases? (2009) (2)
Resection of the inferior vena cava for an isolated para-aortic recurrence of endometrial cancer: report of a case. (2010) (2)
Operative interventions for extrahepatic portomesenteric venous aneurysms and long-term outcomes. (2015) (2)
Unique hepatic gene expression in NASH-candidates for a genetic basis of disease (2001) (2)
Staging of hepatocellular carcinoma (2005) (2)
How matching may impact interpretation: Comments on "A matched-cohort analysis of 192 pancreatic anaplastic carcinomas and 960 pancreatic adenocarcinomas: A 13-year North American experience using the National Cancer Data Base (NCDB)". (2016) (2)
Is mandatory routine caudate lobe resection indicated in hilar cholangiocarcinoma ? (2020) (2)
Quality-of-Life Assessment of Surgical Reconstruction After Laparoscopic CholecystectomyInduced Bile Duct Injuries: What Happens at 5 Years and Beyond? (2004) (2)
Management of hepatic cysts (including hydatid disease) (2002) (2)
Role of Operative Therapy in Non-cirrhotic Patients with Metastatic Hepatocellular Carcinoma (2012) (2)
Impact of FGFR2 gene fusions on survival of patients with intrahepatic cholangiocarcinoma following curative intent resection. (2022) (2)
818 Incidence of Systemic Inflammatory Response Syndrome After Total Laparoscopic Pancreatoduodenectomy - a Comparison With Open Pancreatoduodenectomy (2012) (2)
810 Improved Long-Term Survival After Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy (2012) (2)
Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumors (2021) (2)
Enucleation for Giant Liver Haemangioma (1994) (2)
Successful pregnancy 10 years after triple cardiac valve replacement. (1981) (1)
Management of liver adenomatosis: Partial resection or liver transplantation? (1998) (1)
Is There a Role for Liver Transplantation in the Treatment of Patients With Metastatic Colorectal Cancer? (2019) (1)
Neoadjuvant chemotherapy switch allows for surgical salvage in borderline & locally advanced pancreatic cancer (2021) (1)
Perception versus reality: A National Cohort Analysis of the surgery‐first approach for resectable pancreatic cancer (2021) (1)
Early Thrombotic Events Following Splenectomy for Myelofibrosis: Incidence, Risk Factors and Effect of Pre-Emptive Anticoagulant Therapy (2017) (1)
Hepatocellular carcinoma as predominant cancer subgroup accounting for sex differences in post-hepatectomy liver failure, morbidity and mortality. (2022) (1)
Abstract 1183: miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines (2011) (1)
Hardy's Textbook of Surgery (1984) (1)
Survival after Liver Transplantation for Intrahepatic Cholangiocarcinoma: Analysis of the National Cancer Data Base (2016) (1)
Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial. (2021) (1)
IOERT Treatment Factors (1999) (1)
Radiofrequency Ablation of Neuroendocrine Metastases (2005) (1)
Surgical Anatomy of the Liver and Biliary Tree (1985) (1)
M1505 Choledochal Cysts: Risk of Malignancy and Outcome in 68 Patients Undergoing Surgical Management At a Single Institution (2008) (1)
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors (2022) (1)
Is combined colectomy and hepatectomy for synchrounous metastatic colorectal cancer more efficient than staged (2000) (1)
Chapter 46 – Bile duct cysts in adults (2012) (1)
Ask the Experts: Management of hepatic metastases from neuroendocrine cancer. (2014) (1)
Perioperative Events in Living and Deceased Donor Liver Transplant Recipients: A Case Control Study (2011) (1)
Opinion: Resection of hepatic metastasis for colorectal cancer (1991) (1)
Finding the Balance: General Surgery Resident Versus Fellow Training and Exposure in Hepatobiliary and Pancreatic Surgery. (2020) (1)
Neuroendocrine tumors of the gut (1985) (1)
Association of MicroRNAExpression in Hepatocellular Carcinomas with Hepatitis Infection , Cirrhosis , and Patient Survival (2008) (1)
Surgery of the Alimentary Tract: Pancreas, Biliary Tract, Liver, Spleen (1984) (1)
Chapter 93 – Hepatic metastasis from neuroendocrine cancers (2017) (1)
Postresection Diabetes After Distal Pancreatectomy: Incidence and Risk Factors (2011) (1)
Decreased skeletal muscle is associated with poor survival for patients undergoing surgical resection for pancreatic ductal adenocarcinoma (2016) (0)
Surgical Diseases of the Pancreas (1987) (0)
Su1837 Readmission and Prolonged Hospital Stay After Distal Pancreatectomy: Advantage Laparoscopic Approach (2014) (0)
The spleen in myelofibrosis with myeloid metaplasia. (2004) (0)
Mo1501 Postoperative Systemic Inflammatory Response Syndrome is a Predictor of Major Complication After Pancreatoduodenectomy (2012) (0)
Coil Embolism as Rescue-The Solution to Misperfusion (1999) (0)
Advances in Hepatic, Biliary and Pancreatic Surgery (1986) (0)
The FRA16D common chromosomal fragile site co-localizes with a region of LOH on chromosome 16 in hepatocellular carcinoma (2001) (0)
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for nced Pancreatic Cancer (2019) (0)
899 Pancreaticoduodenectomy With Major Vascular Resection: A Comparisson of Laparoscopic Versus Open Approaches (2014) (0)
Surgical spectrum of familial (hereditary) pancreatitis (1991) (0)
Mo1610 Defining Perioperative Risk After Hepatectomy Based on Diagnosis and Resection Extent (2014) (0)
The Natural History of Metastases to the Liver (1998) (0)
Portomesenteric venous complications following pancreatoduodenectomy: incidence and risk factors (2018) (0)
445 Modern Chemotherapy Mitigates Adverse Prognostic Effect of Regional Nodal Metastases in Stage IV Colorectal Cancer (2013) (0)
Portal Hypertension (2019) (0)
Surgeon performed transversus abdominis plane block (TAP) with liposomal bupivacaine (LP) is an effective adjunct for perioperative analgesia after open liver surgery (2017) (0)
Hepatic Venous Outflow Obstruction in Polycystic Liver Disease (2021) (0)
1034 Frequency of CASH and Its Effect On Surgical Outcomes After Neoadjuvant FOLFOX Therapy for the Treatment of Colorectal Metastasis to the Liver (2009) (0)
Su1557 Major Complication and Open Approach are Predictors of Prolonged Hospital Stay After Pancreaticoduodenectomy (2012) (0)
1026 Pancreatectomy with Concomitant / En Bloc Arterial Resection: Predictors of Morbidity and Mortality (2016) (0)
Doubling Time of Residual Tumor Volume for Metastatic Neuroendocrine Tumors Determines Survival Outcomes after Hepatic Resection (2021) (0)
M1561 Mesentericoportal Vein Resection Does Not Impair Overall Survival or Recurrence-Free Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma (2009) (0)
Curative intent resections for cholangiocarcinoma in primary sclerosing cholangitis (PSC) patients: the Mayo Clinic experience (2021) (0)
Does additional re-resection of a positive proximal margin in hilar cholangiocarcinoma affect survival? Mayo experience (2018) (0)
Portomesenteric venous complications following pancreatic resection: toward development of a clinical scoring system to predict incidence, sequelae and management (2019) (0)
Intraoperative Ultrasonography in Hepatobiliary and Pancreatic Surgery: A Practical Guide (1990) (0)
SURVIVAL FOR RESECTED VERSUS UNRESECTED METASTATIC RENAL CELL CARCINOMA TO THE PANCREAS (2008) (0)
ASO Visual Abstract: Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors (2022) (0)
Cancer of the Gall Bladder and Biliary Tree (2010) (0)
1033 Extent of Resection Does Not Affect the National Failure to Treat Localized Pancreas Cancer with Post-Resection Adjuvant Chemotherapy (2016) (0)
ENDSTAGE LIVER DISEASE (ESLD) PATIENTS HAVE ELEVATED NEUROPEPTIDE (NP) LEVELS WHICH FALL AFTER SUCCESSFUL LIVER TRANSPLANTATION (LT) (1993) (0)
Outcomes of pancreatectomy with portomesenteric venous resection and reconstruction for locally advanced pancreatic neuroendocrine neoplasms. (2021) (0)
Does storage age of transfused blood product components affect short-term outcomes after major hepatectomy? (2016) (0)
Liver Resection and Transplantation for Patients With a Beyond Milan Criteria Hepatocellular Carcinom (2016) (0)
Liver Surgery (Clinical Surgery International series, Vol 12) (1987) (0)
Corrigendum to: Ingested fishbone causing a hepatic abscess. (2021) (0)
Chapter 81B – Metastatic malignant liver tumors: Neuroendocrine (2012) (0)
Perceived vs. Actual Benefit: A National Analysis of the Surgery-First Approach for Resectable Pancreatic Cancer (2017) (0)
A curative intent trimodality approach for advanced isolated abdominal nodal metastasis in metastatic colorectal cancer: Update of a single-institutional experience. (2017) (0)
Outcomes Following Synchronous Resection Of Colorectal Cancer Primary And Liver Metastases (2020) (0)
Neoadjuvant chemotherapy followed by liver resection for patients with metastatic colorectal cancer. (2020) (0)
Sa304 METHYLATED DNA MARKERS IN TISSUE FROM SURGICALLY RESECTED INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS DETECT HIGH-GRADE DYSPLASIA WITH OR WITHOUT INVASIVE CANCER IN THE FIELD (2021) (0)
Surgical and reconstructive outcomes in primary venous leiomyosarcoma. (2021) (0)
Role of Operative Therapy in Treatment of Metastatic and/or Recurrent Gastrointestinal Stromal Tumors (2012) (0)
Surgical management of intrahepatic cholangiocarcinoma: The mayo experience (2020) (0)
ADULT LIVING DONOR LIVER TRANSPLANTATION: DONOR POST-OPERATIVE COAGULATION ALTERATIONS AND TRANSFUSION REQUIREMENTS: 288 (2002) (0)
Invited commentary (2004) (0)
ASO Visual Abstract: Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer (2021) (0)
Laparoscopic pancreatoduodenectomy for patients with borderline resectable pancreatic ductal adenocarcinoma: feasibility and outcomes (2018) (0)
Abstract 413: Preclinical efficacy of platinum based chemotherapy regimens and targeted therapeutics in the first successful described patient derived xenograft model of mixed acinar neuroendocrine carcinoma of the pancreas (2021) (0)
T1738 Surgical Resection of Renal Cell Carcinoma Metastatic to the Pancreas (2008) (0)
Initial results after implementation of a post pancreaticoduodenectomy hemorrhage protocol (2016) (0)
Solid Pseudopapillary Tumors of the Pancreas: Mayo Clinic 20 Years' Experience (2022) (0)
anagement of Giant Hemangioma of the Liver : esection versus Observation (2010) (0)
Pancreatic cancer is more frequently early stage at diagnosis in surgically resected IPMNs with pre-operative surveillance (2022) (0)
Locally recurrent colorectal cancer and hepatic metastases: Safety, feasibility, and outcomes after concomitant resection. (2013) (0)
Invited commentary: “Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer?” (2004) (0)
T1667 Laparoscopic Distal Pancreatectomy: Is There Benefit in Splenic Preservation? (2010) (0)
6. Hepatic resection for metastatic neuroendocrine cancers (1994) (0)
Indocyanine green fluorescent imaging in revisional laparoscopic portal node dissection and liver resection following incidental finding of gallbladder adenocarcinoma after cholecystectomy (2019) (0)
Prognostic factors and effects of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience. (2017) (0)
Fifteen-Year Single Institution Experience With Surgical Treatment of Duodenal Carcinoma: A Comparison of Periampullary and Extra-Ampullary Duodenal Adenocarcinomas (2011) (0)
Hepatoatrial anastomosis and tricuspid valve replacement in Budd-Chiari syndrome 8. (1998) (0)
W1666 Age of Transfused Red Blood Cells and Outcomes After Liver Resection of Hepatocellular Carcinoma (2010) (0)
Non-Traumatic Emergent Pancreatectomy for Neoplastic Disease: Analysis of 534 ACS-Nsqip Patients (2017) (0)
ASO Visual Abstract: Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases-Long-Term Follow-Up of Over 500 Patients. (2023) (0)
Intra and extrahepatic cholangiocarcinoma: An evaluation of adjuvant therapy. (2016) (0)
Invited commentary (2005) (0)
W1525 Factors Associated with Early Liver Recurrence After Pancreatoduodenectomy (2009) (0)
AXIN1 and beta catenin gene mutations in human hepatocellular carcinoma (2001) (0)
A national database analysis of acinar cell carcinoma of the pancreas, a histologically, epidemiologically, and biologically distinct entity increasing in incidence (2021) (0)
ASO Author Reflections: Long-Term Outcomes after Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases. (2023) (0)
Cancer of the Liver and Bile Ducts (2006) (0)
Mo1736 Hepatic Metastasectomy Offers Improves Local Tumor Control Among Patients With Recurrent Colorectal Metastases (2013) (0)
163: PANCREATIC NEUROENDOCRINE TUMORS – A DESCRIPTIVE STUDY OF A RECENT 12-YEAR SURGICAL RESECTION COHORT AT A TERTIARY INSTITUTION (2022) (0)
Resection and Ablation of Metastatic Colorectal Cancer to the Liver (2013) (0)
How I Treat Oligometastatic Colorectal Cancer Through Surgery (2019) (0)
An Unusual Submucosal Tumor in a Pregnant Female: 605 (2008) (0)
Biliary Leaks and Thoracobiliary Fistula (2015) (0)
860 Metabolic Syndrome Is Associated With Increased Post-Operative Morbidity and Hospital Resource Utilization in Patients Undergoing Elective Pancreatectomy: A NSQIP Study of 16,562 Cases (2015) (0)
Mo1493 Safety of a Multimodal Enhanced Recovery Pathway in Liver Resection Surgery (2012) (0)
FRI-365-Efficacy of combined partial hepatectomy and cyst fenestration on health-related quality of life in polycystic liver disease (2019) (0)
Readmissions after pancreatic and liver surgery (2019) (0)
Laparoscopic liver resections for gallbladder cancer and intrahepatic cholangiocarcinoma: the Mayo clinic experience (2021) (0)
Hepatobiliary and pancreatic resection for cholangiocarcinoma in patients with primary sclerosing cholangitis. (2022) (0)
Unroofing and Resection for Benign Nonparasitic Liver Cysts (2016) (0)
A matched cohort study of en bloc venous resection during pancreaticoduodenectomy for adenocarcinoma of the pancreatic head (2005) (0)
Laparoscopic distal pancreatectomy provides equivalent oncologic outcomes compared to open approaches for patients with pancreatic ductal adenocarcinoma (2019) (0)
Tu1779 Impact of Non-Alcoholic Fatty Liver Disease on Long-Term Survival for Resected Intrahepatic Cholangiocarcinoma (2012) (0)
The American Society of Surgical Oncology travel grant. (2015) (0)
Adjuvant hepatic arterial infusional chemotherapy: revisiting the past or a new era? (2011) (0)
Mo1751 Clinical Significance of Portomesenteric Vein Abutment Among Patients With Pancreatic Ductal Adenocarcinoma (2013) (0)
Su1659 Impact of Laparoscopic Approach on Postoperative Pain and Opioid Consumption After Pancreatoduodenectomy (2013) (0)
Improved outcome of women after liver resection is predominantly hepatocellular carcinoma dependent (2021) (0)
Adjuvant Chemotherapy for T2N1 and T3-4 Gallbladder Cancer: A Clear Benefit (2016) (0)
480 Clinical Significance of Re-Resection of Margin-Positive Proximal Bile Duct in Hilar Cholangiocarcinoma (2015) (0)
Surgical Outcomes of Hepatic Resection in Elderly Patients With Colorectal Liver Metastases (2011) (0)
Acinar cell carcinoma of the pancreas: increasing incidence, improved survival (2019) (0)
Hepatic neuroendocrine tumors without an identifiable extrahepatic primary (2018) (0)
Surgical resection and polycystic liver disease (1993) (0)
Imaging of Hilar Cholangiocarcinoma for Liver Transplantation (2014) (0)
Hilar Cholangiocarcinoma with Portal Vein Involvement (2017) (0)
Liver Transplantation with Concurrent Pancreatoduodenectomy for Hilar Cholangiocarcinoma with Common Bile Duct Involvement (2022) (0)
O93 GENE EXPRESSION-BASED PROGNOSTIC SIGNATURE AND GENOMIC CHARACTERIZATION OF FIBROLAMELLAR HEPATOCELLULAR CARCINOMA (2014) (0)
673 Staging and Survival of Resected Hilar Cholangiocarcinoma: an Analysis of 80 Consecutive Patients (2012) (0)
A Curative Intent Trimodality Approach for Advanced Isolated Abdominal Nodal Metastasis in Metastatic Colorectal Cancer: Update of a Single Institutional Experience (2017) (0)
Tu1795 A Multicenter Randomized Controlled Trial to Comparing Pancreatic Leaks With Enhanced Dissection vs. Enhanced Stapling After Distal Pancreatectomy (2015) (0)
Laparoscopic versus open liver resections for intrahepatic cholangiocarcinoma and gallbladder cancer: the Mayo clinic experience. (2022) (0)
Neuroendocrine and noncolorectal liver metastases (2014) (0)
Peritumoral steatosis associated with insulinomas: appearance at imaging (2008) (0)
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplanation (2001) (0)
What is the role of bone marrow-derived stem cells in hepatic hypertrophy after portal vein embolization? (2015) (0)
En bloc celiac axis and extended celiac axis resection with and without revascularization for pancreatic adenocarcinoma (PDAC): the mayo clinic experience (2017) (0)
Is Pancreatectomy with Vascular Resection and Reconstruction for Locally Advanced Pancreatic Neuroendocrine Tumors Safe? (2022) (0)
Management of hepatic metastases from neuroendocrine cancer (2014) (0)
Commentary on: "clinicopathological factors and long-term outcome comparing between lung and peritoneal metastatectomy following hepatectomy for hepatocellular carcinoma in a tertiary institution". (2015) (0)
Surgical Outcomes after Synchronous versus Metachronous Hepatectomy in Patients with Metastatic Pancreatic Neuroendocrine Tumors (2022) (0)
T1660 Pancreatoduodenectomy for Ductal Adenocarcinoma in the Very Elderly; Is it Safe and Justified? (2010) (0)
Current clinical indications and midterm outcomes of surgical portosystemic shunts in adults (2019) (0)
Cholangiocarcinoma with an FGFR2 phenotype: outcomes in patients following surgical resection (2021) (0)
Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of Over 1000 Consecutive Patients. (2023) (0)
Su1641 Portal Venous Thrombosis After Distal Pancreatectomy: Risk Factors and Outcomes (2013) (0)
Counterpoint: Proximal Biliary Strictures Mimicking Hilar Cholangiocarcinoma (2015) (0)
Gastric vascular ectasia do not improve with reduction of portal pressure by transjugular intrahepatic portosystemic shunts (TIPS) (1998) (0)
Small bowel adenocarcinoma in celiac disease: Features and outcomes (2003) (0)
Surgical and Oncologic Outcomes in Patients with BRAF-Mutated Colorectal Cancer Following Targeted Therapy and Hepatic Resection with Curative Intent (2022) (0)
Two Varieties of Intrahepatic Cholangiocarcinoma (1994) (0)
Contemporary outcomes of pancreaticoduodenectomy for benign and precancerous lesions (2021) (0)
M1657 Does BMI/Morbid Obesity Influence Outcomes in Patients Who Have Undergone Pancreatoduodenectomy for Pancreatic Adenocarcinoma? (2010) (0)
Laparoscopic Versus Open Liver Resections for Gallbladder Cancer and Intrahepatic Cholangiocarcinoma: The Mayo Clinic Experience (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David. M. Nagorney?

David. M. Nagorney is affiliated with the following schools:

MD Anderson Cancer Center

David. M. Nagorney's Academic­Influence.com Rankings

Why Is David. M. Nagorney Influential?

David. M. Nagorney's Published Works

Published Works

What Schools Are Affiliated With David. M. Nagorney?

David. M. Nagorney's AcademicInfluence.com Rankings